Radius Health (RDUS) Tops Q1 EPS by 23c, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Radius Health, Inc.: First Quarter 2021 Results
May 7, 2021 6:30 AM EDTTotal net revenue: $56 million vs. $48 million in Q1, 2020, +17% year-over-yearTYMLOS® U.S. product net revenue: $45 million vs. $48 million in Q1, 2020, -6% year-over-yearSignificant operating leverage improvement: Q1, 2021 adjusted EBITDA: ($5) million vs. ($26) million in Q1, 2020Q1, 2021 EPS: ($0.34) vs. ($0.81) in Q1, 2020 Reiterating $250 million for full year 2021 net revenue guidance for the U.S. TYMLOS productHumana added TYMLOS to the formularies of its Medicare Advantage Plans on... More
